Funding for this research was provided by:
National Institutes of Health (NIDDK UM1DK078616, NIDDK UM1DK078616, NIDDK UM1DK078616, NIDDK UM1DK078616, NIA K99AG066849)
Received: 23 February 2022
Accepted: 12 September 2022
First Online: 1 October 2022
: All participants of the Framingham Heart Study provided written informed consent. This study was approved by the Institutional Review Board of the Boston University Medical Campus. All procedures were performed in accordance with relevant guidelines.
: Not applicable.
: The authors declare that they have no competing interests. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.